<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sylvester, Bruce</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Serruys, Patrick</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Coronary Artery Bypass Graft Surgery Superior to Percutaneous Coronary Stenting in Patients with Left Main or Three-Vessel Coronary Disease</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">18-19</style></pages><abstract><style  face="normal" font="default" size="100%">Percutaneous coronary intervention with Taxus (paclitaxel-eluting) stenting was inferior to coronary artery bypass graft with respect to the primary composite of death, stroke, myocardial infarction, or repeat revascularization among patients with left main or 3-vessel coronary artery disease, as reported by researchers from the international SYNergy between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery [SYNTAX; NCT00114972] trial.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>